Diabetes and Metabolic Disorders: Their Impact on Cardiovascular Events in Liver Transplant Patients.


Journal

Canadian journal of gastroenterology & hepatology
ISSN: 2291-2797
Titre abrégé: Can J Gastroenterol Hepatol
Pays: Egypt
ID NLM: 101623613

Informations de publication

Date de publication:
2023
Historique:
received: 03 12 2022
revised: 13 06 2023
accepted: 15 06 2023
medline: 5 7 2023
pubmed: 3 7 2023
entrez: 3 7 2023
Statut: epublish

Résumé

Cardiovascular diseases are currently one of the most important causes of morbidity and mortality in liver transplant patients over the long term. Therefore, evaluating prognostic factors for cardiovascular events (CVEs) in this population is essential for taking preventive measures. The aim of this study was to identify the impact of diabetes and other metabolic disorders on CVEs in liver transplant patients. Three hundred fifty-six liver transplant recipients who survived at least 6 months after surgery were enrolled. Patients were followed for a median time of 118 months (12-250 months). All cardiovascular events were carefully recorded and detailed in the patients' charts. Demographic data, diabetes, hypertension, dyslipidemia, weight changes, and a diagnosis of metabolic syndrome both before and after transplantation were noted to assess their possible relationship with CVE. The presence of a diagnosis of metabolic-associated fatty liver disease (MAFLD) was also evaluated. Immunosuppressive therapy was included in the analysis. Diabetes mellitus (DM), especially when present before transplantation, was strongly associated with CVEs (hazard risk HR 3.10; 95% confidence interval CI: 1.60-6.03). Metabolic syndrome was found to be associated with CVEs in univariate analysis (HR 3.24; 95% CI: 1.36-7.8), while pretransplantation and de novo MAFLD were not. Immunosuppressive therapy had no influence on predisposing transplanted patients to CVEs during follow-up. Further prospective studies may be useful in investigating the risk factors for CVEs after liver transplantation and improving the long-term survival of transplant patients.

Identifiants

pubmed: 37396501
doi: 10.1155/2023/2199193
pmc: PMC10313467
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2199193

Informations de copyright

Copyright © 2023 Simone Di Cola et al.

Déclaration de conflit d'intérêts

The authors declare that there are no conflicts of interest.

Références

Nutrients. 2019 Dec 10;11(12):
pubmed: 31835505
Transpl Int. 2021 Jan;34(1):27-48
pubmed: 33135259
Nutrition. 2020 Jan;69:110573
pubmed: 31585257
Liver Int. 2019 Aug;39(8):1557-1565
pubmed: 31233663
Can J Gastroenterol Hepatol. 2018 Jul 2;2018:2784537
pubmed: 30065915
Clin Mol Hepatol. 2023 Feb;29(Suppl):S286-S301
pubmed: 36577425
Liver Transpl. 2007 Aug;13(8):1109-14
pubmed: 17663411
Best Pract Res Clin Gastroenterol. 2020 Jun - Aug;46-47:101683
pubmed: 33158470
J Hepatol. 2021 Dec;75(6):1284-1291
pubmed: 34380057
J Hepatol. 2020 Jul;73(1):202-209
pubmed: 32278004
Liver Int. 2010 Aug;30(7):948-57
pubmed: 20500807
Clin Gastroenterol Hepatol. 2021 Oct;19(10):2138-2147.e10
pubmed: 33348045
Rev Med Suisse. 2019 Aug 28;15(660):1488-1495
pubmed: 31496172
Am J Manag Care. 2016 Jun;22(7 Suppl):s176-85
pubmed: 27356115
Am J Transplant. 2018 Jan;18(1):207-215
pubmed: 28640504
J Hypertens. 2018 Oct;36(10):1953-2041
pubmed: 30234752
Liver Int. 2014 Oct;34(9):1298-313
pubmed: 24703371
Liver Int. 2014 Aug;34(7):1094-101
pubmed: 24517561
Addict Biol. 2021 Mar;26(2):e12907
pubmed: 32307834
Liver Transpl. 2012 Mar;18(3):370-5
pubmed: 22140067
Eur Heart J. 2020 Jan 7;41(2):255-323
pubmed: 31497854
Transplantation. 2018 May;102(5):727-743
pubmed: 29485508
World J Gastroenterol. 2020 May 14;26(18):2138-2154
pubmed: 32476781
Best Pract Res Clin Gastroenterol. 2020 Jun - Aug;46-47:101681
pubmed: 33158467
Liver Int. 2016 Jul;36(7):936-48
pubmed: 26972930
Ann Gastroenterol. 2015 Apr-Jun;28(2):183-192
pubmed: 25830307
Liver Transpl. 2016 Jun;22(6):796-804
pubmed: 26850091
Atherosclerosis. 2021 Feb;319:51-61
pubmed: 33476944
Eur Heart J. 2016 Oct 14;37(39):2999-3058
pubmed: 27567407
World J Gastroenterol. 2014 Aug 21;20(31):10682-90
pubmed: 25152572
Transplant Proc. 2012 Sep;44(7):2005-6
pubmed: 22974893
J Am Soc Hypertens. 2018 Mar;12(3):220-229
pubmed: 29366595
Liver Transpl Surg. 1997 Jul;3(4):416-22
pubmed: 9346772
PLoS One. 2020 Jan 10;15(1):e0226873
pubmed: 31923179
Nutr Hosp. 2012 Jul-Aug;27(4):1351-6
pubmed: 23165585

Auteurs

Simone Di Cola (S)

Department of Translational and Precision Medicine, Sapienza University of Rome, Viale Dell'Università 37, Rome 00185, Italy.

Giulia Cusi (G)

Department of Translational and Precision Medicine, Sapienza University of Rome, Viale Dell'Università 37, Rome 00185, Italy.

Lucia Lapenna (L)

Department of Translational and Precision Medicine, Sapienza University of Rome, Viale Dell'Università 37, Rome 00185, Italy.

Jakub Gazda (J)

2nd Department of Internal Medicine, Pavol Jozef Safarik University and Louis Pasteur University Hospital, Trieda SNP 1, Kosice 040 11, Slovakia.

Stefano Fonte (S)

Department of Translational and Precision Medicine, Sapienza University of Rome, Viale Dell'Università 37, Rome 00185, Italy.

Marco Mattana (M)

Department of Translational and Precision Medicine, Sapienza University of Rome, Viale Dell'Università 37, Rome 00185, Italy.

Gianluca Mennini (G)

Department of Hepato-Biliopancreatic and Transplant Surgery, Sapienza University of Rome, Viale Del Policlinico 155, Rome 00161, Italy.

Patrizio Pasqualetti (P)

Department of Public Health and Infectious Diseases, Faculty of Pharmacy and Medicine, Sapienza University of Rome, Piazzale Aldo Moro 5, Rome 00185, Italy.

Manuela Merli (M)

Department of Translational and Precision Medicine, Sapienza University of Rome, Viale Dell'Università 37, Rome 00185, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH